Skip to main navigation Skip to search Skip to main content

The spectrum of Patched mutations in a collection of Australian basal cell carcinomas

  • Timothy Evans
  • , Waranya Boonchai
  • , Susan Shanley
  • , Ian Smyth
  • , Susan Gillies
  • , Kylie Georgas
  • , Brandon Wainwright
  • , Georgia Chenevix-Trench
  • , Carol Wicking
  • University of Queensland
  • QIMR Berghofer Medical Research Institute

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

Inactivating mutations in the human patched (PTCH) gene have been identified in both familial and sporadic basal cell carcinomas (BCCs). In some tumors mutations have been detected in both alleles thereby supporting the role of PTCH as a tumor Suppressor gene. We have analyzed 22/23 coding exons of PTCH for mutations in 44 sporadic BCCs, and detected 10 novel mutations in nine tumors. In two of the mutant tumors the remaining allele was inactivated by loss of heterozygosity. Five novel PTCH polymorphisms were also identified. Most of the variations found were C>T substitutions at dipyrimidine sites, supporting previous studies which indicate a role for ultraviolet-B in the genesis of sporadic BCCs. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)43-48
Number of pages6
JournalHuman mutation
Volume16
Issue number1
DOIs
Publication statusPublished - 2000
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Arsenic
  • BCC
  • Basal cell carcinoma
  • NBCCS
  • PTCH
  • Patched

Fingerprint

Dive into the research topics of 'The spectrum of Patched mutations in a collection of Australian basal cell carcinomas'. Together they form a unique fingerprint.

Cite this